Excision Biotherapeutics, Inc.

Calculating rank

USPTO Granted Patents = 2

Forward Citations = 5

Loading Chart...

3 inventors (with patents filed for the assignee):

Kamel Khalili (2 out of 18 patents)

Thomas Malcolm (2 out of 2 patents)

Kenneth I Kohn (2 out of 10 patents)

2 patents: Sort by Forward Citations

1. 11491207 - Gene editing methods and compositions for eliminating risk of JC virus activation and PML (progressive multifocal leukoencephalopathy) during immunosuppressive therapy (2022-11-08),

2. 10279014 - Gene editing methods and compositions for eliminating risk of JC virus activation and PML (progressive multifocal leukoencephalopathy) during immunosuppressive therapy (2019-05-07),

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

2 Patents

#1 in Bedminster

#177 in unknown

Bedminster, undefined

Excision Biotherapeutics, Inc.

Forward Citations = 5

3 inventors:

Kamel Khalili (2 out of 18 patents)

Thomas Malcolm (2 out of 2 patents)

Kenneth I Kohn (2 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Excision Biotherapeutics, Inc.. Retrieved from https://idiyas.com/company/excision-biotherapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]